Literature DB >> 23217598

Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.

Li-Nien Tseng1, Yao-Hsien Tseng, Yi-Der Jiang, Chia-Hsuin Chang, Ching-Hu Chung, Boniface J Lin, Lee-Ming Chuang, Tong-Yuan Tai, Wayne H-H Sheu.   

Abstract

BACKGROUND/
PURPOSE: Cardiovascular complication is the leading cause of mortality in patients with diabetes. Dyslipidemia and hypertension are the major risk factors contributing to cardiovascular disease (CVD). This study was carried out to investigate the prevalence of dyslipidemia and hypertension and their associations with microvascular and macrovascular complications in patients with type 2 diabetes in Taiwan.
METHODS: Health-care data and diagnostic codes were retrieved from the Taiwan Bureau of National Health Insurance claims files for the years 2000-2009. Based on these data the annual prevalences of dyslipidemia and hypertension were calculated and patients were stratified by age, gender, and diabetic complications.
RESULTS: In patients with diabetes, the prevalence of dyslipidemia increased with age, with the highest rate recorded in adults (inclusive of both genders) between 40 and 65 years of age (p for trend <0.001). The prevalence of hypertension also increased with age with the highest rate seen in adults (inclusive of both genders) >65 years of age (p for trend <0.001). The prevalence of stroke and CVD decreased gradually (p for trend 0.025 and <0.001, respectively), while the prevalence of peripheral vascular disease (PVD) increased in patients with diabetes during the study period (p for trend <0.001). The prevalence of dyslipidemia increased in diabetic patients with eye diseases and in men with nephropathies, but decreased in women with nephropathies during the study period. In contrast, the prevalence of dyslipidemia decreased in patients with macrovascular complications, including CVD and cerebrovascular disease (cerebrovascular accident), but increased in those patients with PVD (p for all trends <0.05). In diabetic patients with various macrovascular complications, except PVD, there was a decrease in the prevalence of hypertension in the past 10 years. The prevalence of hypertension increased in patients with microvascular complications including retinopathy, patients on dialysis (inclusive of both genders), and in men with nephropathy. The prevalence of hypertension along with dyslipidemia increased in patients with microvascular complications including retinopathy, patients on dialysis (inclusive of both genders), and in men with nephropathy; however, the rate decreased in all macrovascular complications except in PVD.
CONCLUSION: Although progressively increased prevalence of dyslipidemia and hypertension was observed in patients with diabetes in Taiwan, there was a decrease in the prevalence of stroke and CVD in the past 10 years. Among those with macrovascular diseases, except PVD, there was a trend of decreased prevalence of hypertension and dyslipidemia during the study period. In patients with microvascular diseases, prevalence of hypertension and dyslipidemia in patients with eye diseases increased in the past 10 years. More aggressive management of different risk factors is warranted in diabetic patients with various vascular diseases.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 23217598     DOI: 10.1016/j.jfma.2012.09.010

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  18 in total

1.  Evaluating Adherence to Concomitant Diabetes, Hypertension, and Hyperlipidemia Treatments and Cardiovascular Outcomes Among Elderly Patients Using Marginal Structural Modeling.

Authors:  R Paranjpe; M L Johnson; H Chen; K Birtcher; O Serna; A Mohan; Susan Abughosh
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-09-24

Review 2.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

3.  Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.

Authors:  Hui-Min Hsieh; Song-Mao Gu; Shyi-Jang Shin; Hao-Yun Kao; Yi-Chieh Lin; Herng-Chia Chiu
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 4.  Traditional Risk Factors for Stroke in East Asia.

Authors:  Young Dae Kim; Yo Han Jung; Gustavo Saposnik
Journal:  J Stroke       Date:  2016-09-30       Impact factor: 6.967

5.  Multimorbidity associated with functional independence among community-dwelling older people: a cross-sectional study in Southern China.

Authors:  Xiao-Xiao Wang; Wei-Quan Lin; Xu-Jia Chen; Ying-Yu Lin; Ling-Ling Huang; Sheng-Chao Zhang; Pei-Xi Wang
Journal:  Health Qual Life Outcomes       Date:  2017-04-17       Impact factor: 3.186

6.  Intracellular adhesion molecule-1 K469E gene polymorphism and risk of diabetic microvascular complications: a meta-analysis.

Authors:  Xianghui Su; Xi Chen; Lei Liu; Xiangyun Chang; Xuefeng Yu; Kan Sun
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

7.  The chromosome 9p21 variant not predicting long-term cardiovascular mortality in Chinese with established coronary artery disease: an eleven-year follow-up study.

Authors:  I-Te Lee; Mark O Goodarzi; Wen-Jane Lee; Jerome I Rotter; Yii-der Ida Chen; Kae-Woei Liang; Wen-Lieng Lee; Wayne H-H Sheu
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

8.  Association of blood pressure with development of metabolic syndrome components: a five-year Retrospective Cohort study in Beijing.

Authors:  Da Huo; Lixin Tao; Xia Li; Wei Wang; Zhaoping Wang; Dongning Chen; Huiping Zhu; Xinghua Yang; Yanxia Luo; Xiuhua Guo
Journal:  BMC Public Health       Date:  2013-10-02       Impact factor: 3.295

9.  Interactions of Six SNPs in ABCA1gene and Obesity in Low HDL-C Disease in Kazakh of China.

Authors:  Ming-hong Yao; Heng Guo; Jia He; Yi-zhong Yan; Ru-lin Ma; Yu-song Ding; Jing-yu Zhang; Jia-ming Liu; Mei Zhang; Shu-gang Li; Shang-zhi Xu; Qiang Niu; Jiao-long Ma; Shu-xia Guo
Journal:  Int J Environ Res Public Health       Date:  2016-01-28       Impact factor: 3.390

10.  Value of Chromosome 9p21 Polymorphism for Prediction of Cardiovascular Mortality in Han Chinese Without Coronary Lesions: An Observational Study.

Authors:  I-Te Lee; Kae-Woei Liang; Jun-Sing Wang; Wen-Jane Lee; Yii-der Ida Chen; Shih-Yi Lin; Wen-Lieng Lee; Wayne H-H Sheu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.